Key Points
- Maxim Shishin sold 2,400 shares of CorVel on March 16 at an average price of $54, reducing his position by 25.4% to 7,050 shares (transaction filed with the SEC).
- CorVel shares opened at $53.96, trade between a 52-week low/high of $44.83/$119.57, and the company has a market cap of about $2.76 billion with a P/E of 26.45.
- The company reported $0.47 EPS and $235.6 million in revenue for the quarter, with a 30.15% ROE and 11.23% net margin, while analysts maintain a consensus "Hold" rating.
CorVel Corp. (NASDAQ:CRVL - Get Free Report) insider Maxim Shishin sold 2,400 shares of CorVel stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $54.00, for a total transaction of $129,600.00. Following the completion of the sale, the insider owned 7,050 shares of the company's stock, valued at $380,700. This trade represents a 25.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
CorVel Stock Up 0.4%
Shares of NASDAQ CRVL opened at $53.96 on Wednesday. The business's 50 day moving average is $57.79 and its two-hundred day moving average is $68.80. CorVel Corp. has a 52-week low of $44.83 and a 52-week high of $119.57. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of 26.45 and a beta of 1.10.
CorVel (NASDAQ:CRVL - Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The business services provider reported $0.47 EPS for the quarter. CorVel had a return on equity of 30.15% and a net margin of 11.23%.The business had revenue of $235.63 million during the quarter.
Analyst Ratings Changes
Separately, Weiss Ratings restated a "hold (c)" rating on shares of CorVel in a report on Friday, January 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold".
View Our Latest Analysis on CorVel
Institutional Investors Weigh In On CorVel
Hedge funds have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. grew its stake in shares of CorVel by 66.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider's stock worth $39,000 after acquiring an additional 230 shares in the last quarter. Corient Private Wealth LLC increased its position in shares of CorVel by 40.7% during the fourth quarter. Corient Private Wealth LLC now owns 12,609 shares of the business services provider's stock worth $854,000 after acquiring an additional 3,648 shares during the period. Virtu Financial LLC acquired a new stake in shares of CorVel in the fourth quarter valued at $485,000. State of Tennessee Department of Treasury raised its stake in shares of CorVel by 5.9% in the fourth quarter. State of Tennessee Department of Treasury now owns 15,782 shares of the business services provider's stock valued at $1,099,000 after acquiring an additional 873 shares in the last quarter. Finally, SkyView Investment Advisors LLC boosted its holdings in CorVel by 2.1% in the fourth quarter. SkyView Investment Advisors LLC now owns 14,882 shares of the business services provider's stock valued at $1,007,000 after purchasing an additional 307 shares during the period. 51.36% of the stock is currently owned by institutional investors and hedge funds.
CorVel Company Profile
(
Get Free Report)
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers' compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel's integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company's product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
